579 results on '"Schubert, Mark"'
Search Results
52. Evidence that TRPC1 contributes to calcium-induced differentiation of human keratinocytes
53. Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer
54. Allergic Fungal Sinusitis: Pathogenesis and Management Strategies
55. Continuing Education During Times of War: Experiences of Children in Northern Sri Lanka
56. Development of a mechatronics laboratory--eliminating barriers to manufacturing instrumentation and control
57. Fungal rhinosinusitis: Diagnosis and therapy
58. Ancillary Therapy and Supportive Care of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. Ancillary Therapy and Supportive Care Working Group Report
59. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group Report
60. Rhinosinusitis: Developing guidance for clinical trials
61. Griffith’s Transnational Fijians: Between the Devil, the Deep Blue Sea…and their Pastors
62. Oral Chronic Graft versus Host Disease
63. Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)
64. Wood–Gelatin Bio-Composite Membranes with Tunable Flux
65. Applying machine learning to predict the tensile shear strength of bonded beech wood as a function of the composition of polyurethane prepolymers and various pretreatments
66. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report
67. A Phase I/II Study of Mycophenolate Mofetil in Combination with Cyclosporine for Prophylaxis of Acute Graft-versus-Host Disease after Myeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation
68. Cultured Epithelial Cells Response to Phototherapy With Low Intensity Laser
69. Updated Clinical Practice Guidelines for the Prevention and Treatment of Mucositis
70. HLA-DQB1∗03 in allergic fungal sinusitis and other chronic hypertrophic rhinosinusitis disorders
71. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: An emerging oral complication of supportive cancer therapy
72. Oral Complications and Management Considerations in Patients Treated with High-Dose Chemotherapy
73. Managing pain in mucositis
74. A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy
75. Predictors of Oral Mucositis in Patients Receiving Hematopoietic Cell Transplants for Chronic Myelogenous Leukemia
76. Identifying and treating HIV-related oral conditions: a clinical grand rounds approach
77. Perspectives on cancer therapy-induced mucosal injury
78. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
79. Use of intralesional interferon-α for the treatment of recalcitrant oral warts in patients with AIDS: A report of 4 cases
80. Antileukotriene therapy for allergic fungal sinusitis
81. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders
82. CHRONIC RHINOSINUSITIS
83. Oral Mucositis and the Clinical and Economic Outcomes of Hematopoietic Stem-Cell Transplantation
84. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial
85. Medical treatment of allergic fungal sinusitis
86. Routine dental diagnostic imaging in hematopoietic cell transplantation
87. Oral mucositis in myelosuppressive cancer therapy
88. Physisporinus vitreus: a versatile white rot fungus for engineering value-added wood products
89. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307
90. Oral Complications of Chronic Graft-Versus-Host Disease
91. Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211.
92. Factors associated with osteonecrosis of the jaw in women with breast cancer receiving high-dose bisphosphonates to prevent breast cancer metastases as part of the SWOG 0307 trial.
93. Micronized copper-treated wood: copper remobilization into spores from the copper-tolerant wood-destroying fungus Rhodonia placenta
94. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy
95. Community participation for malaria elimination in tafea province, vanuatu: part ii. social and cultural aspects of treatment-seeking behaviour
96. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up
97. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis
98. Radial basis function neural networks for modeling growth rates of the basidiomycetes Physisporinus vitreus and Neolentinus lepideus
99. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation: development of an oral mucositis index
100. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.